SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

Modest Protein Restriction Tied to Better Outcomes in CKD

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

Inhaled Insulin Okayed for Kids With Diabetes Aged 6+ Years

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

The Latest in GLP-1-Based Therapy to be Featured at ADA

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

Processed Meat May Raise Gastric and Oesophageal Cancer Risk

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Continuous Glucose Monitoring: Is It Time to Expand Use?

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-Restricted Eating Reshapes Gut Flora, Aids Weight Loss

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Latest News

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

News All Time

EMA Panel Backs Weekly Hormone for Child Growth Disorders

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age and those with Noonan syndrome, potentially reducing injection burden.

Europe Moves Closer to New Retinal Disease Biosimilar

A new anti-VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Dexcom Warns Patients as Stolen Glucose Sensors Hit the Market

Medical device maker Dexcom said on Tuesday some of its glucose ⁠sensors slated for destruction were instead stolen and sold, prompting the company ⁠to warn users not to use...

Weight Loss Alone May Not Prevent T2D in Some Patients

Prediabetes management often emphasizes weight loss, but a long-term follow-up study found that for some older adults, thinner isn’t always better.

Telephone Weight-Loss Coaching Pays Off in Breast Cancer

Among women with overweight or obesity and early breast cancer, those with the poorest physical function and mental health at baseline appear to benefit the most from telephone weight-loss coaching.

GLP-1s Tied to Weight Loss in Real-World Rheumatologic Care

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

FRAX Predicts Surgery Benefit in Hyperparathyroidism

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may nevertheless benefit from the surgery.

Serum Acylcarnitines May Predict Kidney Decline in Diabetes

Specific serum acylcarnitine levels are linked to faster kidney function decline in type 2 diabetes and can help improve the prediction of patients at highest risk for rapid decline.

Tirzepatide Yields Early Weight Loss, Later Plateau

Modeling finds marked early weight loss with tirzepatide that later plateaus as appetite returns and energy expenditure decreases, and discontinuation of the drug is linked to partial weight regain.

Stigma Negatively Affects Postbariatric Outcomes

Weight bias, stigma, and discrimination are linked to poorer mental health and weight outcomes after bariatric surgery, although the long-term physical effects remain understudied.

The Sweetener Trap: Are Sugar Alternatives Backfiring?

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than previously recognized.

Bayer Says FDA Grants Priority Review Designation for Finerenone

Bayer said on Thursday ⁠that the U.S. Food and ⁠Drug Administration had accepted its ⁠supplemental New ‌Drug Application for finerenone and granted priority review...

BioMarin's Drug Shows Significant Growth Gains in Children in Late-stage Trial

BioMarin Pharmaceutical said on Wednesday its treatment for a rare condition that ⁠leads to short stature helped boost growth in children, meeting the main goal of a...

Diabetic Peripheral Neuropathy Tied to Dementia Risk in T2D

Diabetic peripheral neuropathy above a certain vibration perception threshold is linked to a notably higher risk for dementia in patients with type 2 diabetes, according to a Danish cohort study.

Finding the Next Weight-Loss Drug in Python Blood

Pythons can go weeks without eating. Now researchers have isolated an appetite-suppressing metabolite in python blood that could spur a new weight-loss therapy.

Diabetes Meds Show Varied Associations With Liver Protection

Different antidiabetic drug classes show distinct associations with the risk for major adverse liver outcomes among patients with type 2 diabetes, according to a network meta-analysis.

Recommended News For You

Base Treatment Decisions in Metastatic Breast Cancer on Presence of ESR1 Mutations

De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer

King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?

'It's rare and it's scary.' Dark spot on your fingernail could mean cancer

Modified personalized cancer vaccine generates powerful immune response

Early Results for Anorexia Nervosa with Psilocybin.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Recommended Articles For You

Understanding Epidural Hematoma: Symptoms, Causes and Treatment  

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization 

ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.

2.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

3.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

4.

Screening for prostate cancer: is it time to give up digital rectal examination?

5.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.

1.

Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier

2.

Unpacking the Importance of White Blood Cells (WBCs) in the Body 

3.

Breast Cancer Secrets: AI-Powered Precision Medicine

4.

The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond

5.

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

3.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot